Reducing Piperacillin and Tazobactam Use for Pediatric Perforated Appendicitis

Talal B Seddik1, Lauren A Rabsatt2, Claudia Mueller3

  • 1Pediatric Infectious Diseases, Stanford University School of Medicine, Stanford, California.

Insights

An intervention successfully reduced piperacillin and tazobactam (PT) use in pediatric perforated appendicitis. This change did not affect clinical outcomes, demonstrating a safe approach to antibiotic stewardship.

Area of Science:

  • Pediatric Surgery
  • Infectious Diseases
  • Antibiotic Stewardship

Background:

  • Perforated appendicitis often leads to infectious complications, but optimal antibiotic selection remains debated.
  • Piperacillin and tazobactam (PT) is a broad-spectrum antibiotic frequently used in such cases.
  • There is a need to evaluate strategies for reducing PT use while maintaining patient safety.

Purpose of the Study:

  • To assess the effectiveness and safety of an intervention aimed at decreasing piperacillin and tazobactam (PT) use in pediatric acute perforated appendicitis.
  • To evaluate the impact of provider education and electronic order modification on PT utilization.

Main Methods:

  • A single-center, retrospective cohort study included children (≤18 years) undergoing appendectomy for perforated appendicitis.
  • An intervention involved provider education followed by electronic antibiotic order modification to default to ceftriaxone and metronidazole.
  • Preintervention and postintervention PT exposure and clinical outcomes were compared.

Main Results:

  • Piperacillin and tazobactam (PT) exposure decreased significantly from 78% to 18% post-intervention (P < 0.001).
  • Use of PT for at least half of intravenous antibiotic days also dropped significantly from 78% to 13% (P < 0.001).
  • No significant differences were observed in antibiotic duration, length of stay, surgical site infection rates, or 30-day readmission rates.

Conclusions:

  • Provider education and electronic antibiotic order changes effectively reduced piperacillin and tazobactam (PT) use in pediatric perforated appendicitis.
  • The intervention was safe, as evidenced by the lack of negative impact on key clinical outcomes.
  • This study supports targeted interventions for antibiotic stewardship in pediatric surgical infections.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
110
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
273
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
147
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
1.3K
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
118